România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

biosafety technologies ltd -

Republica Moldova - română - ANSA (Agenţia Naţională pentru Siguranţa Alimentelor)

provimi ltd., franța - dextroză, - soluţie orală

Uniunea Europeană - română - EMA (European Medicines Agency)

biogen netherlands b.v. - fumarat de dimetil - scleroză multiplă - imunosupresoare - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Uniunea Europeană - română - EMA (European Medicines Agency)

biogen netherlands b.v. - peginterferon beta-1a - scleroză multiplă - imunostimulante, - tratamentul sclerozei multiple recurente remisive la pacienții adulți.

Uniunea Europeană - română - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - scleroză multiplă - imunosupresoare selective - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 și 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Uniunea Europeană - română - EMA (European Medicines Agency)

biogen netherlands b.v. - nusinersen sodic - atrofia musculară, spinală - alte medicamente pentru sistemul nervos - spinraza este indicat pentru tratamentul atrofiei musculare spinale 5q.